PGx testing provides insight into how patients may respond to certain medications based on DNA variants that affect pharmacokinetics and pharmacodynamics.
PGx testing equips physicians with a tool to enhance effective treatment decisions, potentially minimize the risk of adverse drug reaction, maximize efficacy, and reduce “trial and error” dosing and drug selection.
We offer a comprehensive PGx panel with over 30 genes and 250+ medications in the treatment areas of:
